On October 31, the U.S. District Court for the Eastern District of Virginia granted a preliminary injunction blocking the U.S. Patent Office’s Claims and Continuations Rules from taking effect. While the rules are on hold, nutraceutical companies need to remain informed so they can make decisions that will maximize the value of their patent portfolios during these uncertain times. In her byline on www.nutraingredients-usa.com, Foley’s Courtenay Brinckerhoff highlights some of the arguments by Smithkline Beecham Corporation (GSK), who challenged the court on the rules, as well as the court’s decisions and the possible impact on nutraceutical companies
Click here for the full article.
Author(s)
Related Insights
03 October 2024
Innovative Technology Insights
I Build Generative AI Technology: Does California’s New Transparency Requirement Apply to Me?
FAQs for developers of generative AI models and applications.
04 October 2024
Events
Fundamentals – Federal Anti-Kickback Statute and Federal Physician Self-Referral Law
Foley partner Jana Kolarik is speaking at the University of Florida Law’s inaugural Health Law Symposium.
02 October 2024
Manufacturing Industry Advisor
Foley Automotive Update
Foley is here to help you through all aspects of rethinking your long-term business strategies, investments, partnerships, and technology. Contact the authors, your Foley relationship partner, or our Automotive Team to discuss and learn more.